PAULSON CAPITAL SC 13G AVI BIOPHARMA

Company

Sarepta Therapeutics, Inc.

Filed

April 14, 2004

Accession Number

0001015402-04-001460

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →